Gyre Therapeutics (GYRE) Other Non Operating Income: 2015-2025
Historic Other Non Operating Income for Gyre Therapeutics (GYRE) over the last 9 years, with Sep 2025 value amounting to $727,000.
- Gyre Therapeutics' Other Non Operating Income rose 1069.33% to $727,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$945,000, marking a year-over-year decrease of 260.69%. This contributed to the annual value of -$1.7 million for FY2024, which is 9.29% down from last year.
- Latest data reveals that Gyre Therapeutics reported Other Non Operating Income of $727,000 as of Q3 2025, which was up 601.38% from -$145,000 recorded in Q2 2025.
- Over the past 5 years, Gyre Therapeutics' Other Non Operating Income peaked at $858,000 during Q4 2022, and registered a low of -$1.6 million during Q4 2024.
- In the last 3 years, Gyre Therapeutics' Other Non Operating Income had a median value of -$72,000 in 2024 and averaged -$167,727.
- Per our database at Business Quant, Gyre Therapeutics' Other Non Operating Income surged by 4,390.00% in 2022 and then crashed by 133,200.00% in 2023.
- Over the past 5 years, Gyre Therapeutics' Other Non Operating Income (Quarterly) stood at -$20,000 in 2021, then spiked by 4,390.00% to $858,000 in 2022, then plummeted by 127.62% to -$237,000 in 2023, then crashed by 589.45% to -$1.6 million in 2024, then soared by 1,069.33% to $727,000 in 2025.
- Its Other Non Operating Income was $727,000 in Q3 2025, compared to -$145,000 in Q2 2025 and $107,000 in Q1 2025.